Last $155.30 USD
Change Today -5.26 / -3.28%
Volume 742.4K
JAZZ On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 5:20 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kathryn E. Falberg

AgeTotal Calculated CompensationThis person is connected to 59 board members in 4 different organizations across 14 different industries.

See Board Relationships
53$2,692,955
As of Fiscal Year 2013

Background*

Ms. Kathryn E. Falberg, also known as Kate, has been a Consultant to Jazz Pharmaceuticals Public Limited Company since March 9, 2014. Ms. Falberg served as the Chief Financial Officer of Jazz Pharmaceuticals Public Limited Company from 2009 to March 9, 2014 and its Executive Vice President from March 2012 to February 2014. Ms. Falberg serves as the Chief Financial Officer and Senior Vice President of Azur Pharma Public Limited Company. She served as Senior Vice President ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 634 7800
Fax: --

Board Members Memberships*

Director
Director
Director
2002-N/A
Former Director, Member of Audit Committee and Member of Compensation Committee
2004-N/A
Former Independent Director
2007-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2009-2012
Former Director, Chairman of Audit & Risk Committee and Member of Corporate Governance & Nominating Committee
2013-Present
Director, Chairman of Audit Committee and Chairman of Nominating & Corporate Governance Committee

Education*

BA
University of California-Los Angeles
MBA
University of California-Los Angeles

Other Affiliations*

Annual Compensation*

Salary$472,693
Total Annual Compensation$472,693

Stock Options*

Restricted Stock Awards$946,080
All Other Compensation$3,622
Exercised Options44,216
Exercised Options Value$2,289,504
Exercisable Options33,537
Exercisable Options Value$3,076,759
Unexercisable Options82,417
Unexercisable Options Value$6,310,070
Total Value of Options$11,676,332
Total Number of Options160,170

Total Compensation*

Total Annual Cash Compensation$856,315
Total Short Term Compensation$472,693
Other Long Term Compensation$949,702
Total Calculated Compensation$2,692,955
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JAZZ:US $155.30 USD -5.26

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Rajat Rai Chief Executive Officer
Akorn, Inc.
$250.0K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAZZ PHARMACEUTICALS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.